The recent resignation of Dr. Peter Marks, the FDA’s top vaccine official, has sent shockwaves through the biopharma industry. Marks cited misinformation propagated by Robert F. Kennedy Jr. as the primary reason for his departure. In a series of statements, he condemned Kennedy for spreading lies about vaccine safety and emphasized his unwillingness to continue in a role influenced by disinformation. This shake-up comes at a time when public confidence in vaccines is crucial, raising concerns about the implications for public health and the biotech sector.